Pathogenesis of diabetic retinopathy and strategy to develop new therapeutic modalities

Ophthalmologica

Volumn 218, Issue SUPPL. 1, 2004, Pages 19-28

  Yamashita, Hidetoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; RUBOXISTAURIN; STATIN; STEROID;

CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFICACY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; NONHUMAN; PREVALENCE; PROLIFERATIVE RETINOPATHY;

EID: 4444271487     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079463     Document Type: Conference Paper

References (24)

1. Knowler WC, Barrett-Connor E, Fowler SE, et al: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
2. Sone H, Ito H, Ohashi Y, et al: Obesity and type 2 diabetes in Japanese patients. Lancet 2003;361:85.
3. Klein R, Klein BE, Moss SE, et al: The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532.
4. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clinc Pract 1995;28:103-117.
5. Leske MC, Wu S-Y, Hennis A, et al: Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthamology 2003;110:941-947.
6. Funatsu H, Hori S, Yamashita H: Rate of progression of diabetes retinopathy. Jpn Rev Clin Ophthalmol 1993;87:976-982.
7. Nakagami T, Kawahara R, Hori S, et al: Effect of diabetic control on the development of retinopathy in non-insulin dependent diabetes mellitus. J Japan Diab Soc 1996;39:901-906.
8. Klein R, Klein BE, Moss E, et al: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864-2871.
9. Klein BEK, Davis MD, Segal P, et al: Diabetic retinopathy. Assessment of severity and progression. Ophthalmology 1984;91:10-17.
10. Garg SK, Marshall G, Chase HP, et al: The use of the Markov process in describing the natural course of diabetic retinopathy. Arch Ophthalmol 1990;108:1245-1247.
11. Nathan D: 10 years after the DCCT: From DCCT to EDIC and beyond. International Diabetes Federation Congress, Paris, August 2003.
12. Nathan D: The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
13. Nathan D: DCCT/EDIC Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389.
14. Ceriello A: New insights on oxidative stress and diabetic complications may lead to a 'causal' antioxidant therapy. Diabetes Care 2003;26:1589-1596.
15. Brownlee M: Biochemistry and Molecular Cell Biology of Diabetic Complications. International Diabetes Federation Congress, Paris, August 2003.
16. Yamashita H, Horie K, Yamamoto T, et al: Superoxide dismutase in developing mouse retina. Jpn J Ophthalmol 1994;38:148-161.
17. Fujii T, Mori K, Takahashi Y, et al: Immunohistochemical study of glutathione reductase in rat ocular tissues at different developmental stages. Histochem J 2001;33:267-272.
18. Fujii T, Ikeda Y, Yamashita H, et al: Transient elevation of glutathione peroxidase 1 around the time of eyelid opening in the neonatal rat. J Ocul Pharmacol Ther 2003;19:361-369.
19. De La Cruz P, Arrebola M, Gonzalez-Correa A, et al: Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats. Naunyn-Schmiedeberg's Arch Pharmacol 2003;367:204-210.
20. Funatsu H, Yamashita H, Noma H, et al: Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol 2001;45:577-584.
21. Sato S, Katagiri Y, Goto K: Immunohistochemical observation of diacylglycerol kinase in normal and the early stage of diabetic rat. ARVO Meeting, USA, 2003.
22. Funatsu H, Yamashita H, Nakanishi Y, et al: Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol 2002;86:311-315.
23. Yamane K, Minamoto A, Yamashita H, et al: Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2003;2:1177-1187.
24. Saitoh K, Sato H, Kawasaki R: Posterior subtenon's jnjection of triamcinolon acetonide for macular edema. Folia Ophthalmol Jpn 2004;55:100-104.